Market Analysis
The global drug device combination market share is predicted to grow at a whopping 7.2% CAGR over the assessment period 2023-2032. Drug-device combination products relate a drug with that of a medical device to bridge various regulatory frameworks (device or drug). This can be a single product having several components such as drug-eluting stents, transdermal patches...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian